Somaxon Pharmaceuticals Inc (NASDAQ:SOMX.DL)
CAPS Rating:
A pharmaceutical company focused on the in-licensing and development of proprietary product candidates for the treatment of diseases and disorders in the fields of psychiatry and neurology.
RSS Headlines
Fool UK
Recs
Marketing deal with P&G for Silenor is a big, big deal.